Pharma Stocks in Focus After Q1 Results: Neuland, FDC & Cohance
Pharma stocks are on the radar once again post Q1 FY27 results with new perspectives on earnings and growth. Both ...
Pharma stocks are on the radar once again post Q1 FY27 results with new perspectives on earnings and growth. Both ...
Schneider Electric Infrastructure Ltd. is emerging as a strong play on India’s electrification, infrastructure modernisation and digitalisation themes. The company ...
Balu Forge share price has attracted increasing investor attention as the company moves beyond its traditional forging business and expands ...
The world is a new place where regional economic trends are becoming increasingly important. Germany is grappling with sluggish growth ...
AI is already one of the hottest investment themes in the world's markets, making AI stocks a growing area of ...
If you've searched HFCL share price recently, you've probably noticed something unusual: this isn't a typical stock-in-focus story built around ...
This blog would make you understand which FMCG Stocks performed better in the last quarter of FY27 by taking a ...
Borosil share price is currently trading at around ₹237.05, down 2.84% today. The stock remains nearly 42% below its 52-week ...
Institutional flows are now indicating a return to Indian equities, but it is not as simple as one day of ...
Sreeleathers share price is back in focus as the Kolkata-based footwear retailer attempts to break out of a multi-year downward-sloping ...
Engineers India share price today is trading around ₹225–₹245, and all eyes are on the company as its board meets ...
AXISCADES Technologies share price is down 0.54% today to ₹1,535.10, pulling back from the ₹1,598–1,631 zone it was trading in ...
India’s jewellery market is facing an interesting contradiction. Gold prices remain elevated, yet consumers are still spending heavily on jewellery ...
Tata Motors CV share price has spent the last two months doing something a lot of momentum investors like to ...
GIC Re share price has been under pressure after the Government of India's Offer for Sale (OFS) priced at a ...
India's AI-powered, SEBI-registered investment advisory — research, portfolios and global market intelligence for every investor.
Customer support customersupport@jarvisinvest.com
Jarvis Invest — SEBI Registered Investment Adviser (Reg. No. INA000013235) & SEBI Registered Research Analyst (Reg. No. INH000018762). Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
© 2026 Jarvis Invest. All rights reserved.